Cytovation

The power of immunotherapy can be directed at multiple diseases – from benign tumors to malignant cancers.

Latest funding

$6M · April 23, 2025

Total raised: $14M across 2 sourced rounds

Website: cytovation.com.

X: @cytovation · 179 followers.

Category: Health and bio.

Sectors: Biotechnology, Life Science, Medical.

Stage: Series A.

Based in: Bergen, Norway.

Total raised: $14M in 2 sourced rounds.

Last round: Apr 23, 2025 · 568 days ago.

On Recent Funding since: Nov 8, 2026.

Signals

X account@cytovation · created Feb 22, 2016 (10 years old) · 179 followers

Website registeredJun 24, 2014 (12 years old)

About Cytovation

CyPep-1 is a first-in-class tumor membrane targeted immunotherapy for the treatment of solid tumors.

TIMELINE · MONEY RAISED

@cytovation·Raised $14M in 2 sourced rounds·2 signals before the first raise

Money raised, round by round (amounts linked to their source). Pins are dated signals; hover the icons for dates.

LP
Lars Prestegarden co-founder and Chief Executive Officer (CEO)

source: cytovation.com

Sources and API

Every amount links to the page it came from. * Estimated from an accelerator's published standard deal, not a company-specific disclosure. How Recent Funding sources and verifies funding data. The same data as JSON: /api/v1/companies/cytovation (get a free API key).